You just read:

CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Skin Cancer Therapies

News provided by

Cannabis Science, Inc.

Jan 31, 2013, 09:02 ET